Telangiectasia macularis eruptiva perstans
We’re all in this for good.
- help each other live better and uncover the best ways to manage your health today
- help researchers shorten the path to new treatments tomorrow
How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.
What is telangiectasia macularis eruptiva perstans?
Telangiectasia macularis eruptiva perstans (TMEP) is the accumulation of mast cells in the skin. Mast cells are apart of the body's immune system and help to regulate allergic reactions. TMEP skin lesions appear pink-brown in color.
Common symptoms reported by people with telangiectasia macularis eruptiva perstans
Treatments taken by people with telangiectasia macularis eruptiva perstans

Let’s build this page together! When you share what it’s like to have telangiectasia macularis eruptiva perstans through your profile, those stories and data appear here too.
Got a question about living with telangiectasia macularis eruptiva perstans? Members in the forum might have the answers.
Compare treatments taken by people with telangiectasia macularis eruptiva perstans

Let’s build this page together! When you share what it’s like to have telangiectasia macularis eruptiva perstans through your profile, those stories and data appear here too.
Got a question about living with telangiectasia macularis eruptiva perstans? Members in the forum might have the answers.
Who has telangiectasia macularis eruptiva perstans on PatientsLikeMe?
- 18 patients have this condition
- 0 new patients joined this month
- 13 say telangiectasia macularis eruptiva perstans is their primary condition
Age | Proportion | # of patients |
---|---|---|
<20 | 1 | |
20s | 1 | |
30s | 1 | |
40s | 5 | |
50s | 6 | |
60s | 3 | |
70+ | 1 |
Age at first symptom | Proportion | # of patients |
---|---|---|
0-19 years | 0 | |
20-29 years | 1 | |
30-39 years | 1 | |
40-49 years | 0 | |
50-59 years | 3 | |
60-69 years | 0 | |
70+ years | 0 |
Distribution of sex
Sex | Proportion | # of patients |
---|---|---|
Male | 6 | |
Female | 12 |
Diagnosis status | Proportion | # of patients |
---|---|---|
Diagnosed | 5 | |
Not Diagnosed | 0 |